Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2006 2
2007 2
2008 1
2009 2
2010 3
2012 3
2013 4
2014 4
2015 3
2016 5
2017 7
2018 5
2019 4
2020 5
2021 3
2022 5
2023 6
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Climate change and tuberculosis: an analytical framework.
Saunders MJ, Boccia D, Khan PY, Goscé L, Gasparrini A, Clark RA, Pescarini JM, Charalambous S, Fekadu L, Dockhorn da Costa Johansen F, Vasilyeva I, Narendran G, Li T, Ndjeka N, White RG, Houben RMGJ, Zignol M, Gebreselassie N, McQuaid CF. Saunders MJ, et al. Lancet Respir Med. 2025 Oct 30:S2213-2600(25)00329-7. doi: 10.1016/S2213-2600(25)00329-7. Online ahead of print. Lancet Respir Med. 2025. PMID: 41177169 Review.
Climate change and tuberculosis: an analytical framework.
Saunders MJ, Boccia D, Khan PY, Goscè L, Gasparrini A, Clark RA, Pescarini JM, White RG, Houben RM, Zignol M, Gebreselassie N, McQuaid CF. Saunders MJ, et al. medRxiv [Preprint]. 2025 Feb 20:2025.02.18.25322451. doi: 10.1101/2025.02.18.25322451. medRxiv. 2025. Update in: Lancet Respir Med. 2025 Oct 30:S2213-2600(25)00329-7. doi: 10.1016/S2213-2600(25)00329-7. PMID: 40034780 Free PMC article. Updated. Preprint.
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
Sinha A, Klebe R, Rekart ML, Alvarez JL, Skrahina A, Yatskevich N, Solodovnikova V, Viatushka D, Parpieva N, Safaev K, Liverko I, Tigay Z, Moe S, Khristusev A, Allamuratova S, Mirzabaev S, Achilov M, Samieva N, Lachenal N, Merle CS, Sall FB, Restrepo CG, Tan C, Sitali N, Saunders MJ. Sinha A, et al. Clin Infect Dis. 2025 Nov 6;81(4):838-845. doi: 10.1093/cid/ciaf035. Clin Infect Dis. 2025. PMID: 39964841 Free PMC article.
77 results